Michael Penn
Key details
- Job title: Vice president, IP
- Organisation:BlueRock Therapeutics
Michael Penn is vice president of IP at BlueRock Therapeutics. He specialises in patent prosecution, IP diligence, IP transactions and contracts, and venture capital investments.
Prior to joining BlueRock Therapeutics, he held similar leadership roles as vice president of IP at Instil Bio, and previously served as principal counsel and senior counsel at Amgen, where he worked on a broad range of IP matters including patent strategy, litigation support, and portfolio management. He also served as chief patent counsel at bioMérieux, overseeing patent-related legal functions.
Earlier in his career, he practised as corporate counsel at MedImmune and as an associate at Sterne, Kessler, Goldstein & Fox. He also worked as a patent examiner at the US Patent and Trademark Office.
Before transitioning into law, he had a scientific career as a scientist at Genetic Therapy.
